Takato Takeuchi

Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study

Ryotaro Bouchi, Masahiro Terashima, Yuriko Sasahara et al. · Cardiovascular Diabetology · 2017 · 173 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study

Tatsuya Fukuda, Ryotaro Bouchi, Masahiro Terashima et al. · Diabetes Therapy · 2017 · 124 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study

Tatsuya Fukuda, Ryotaro Bouchi, Takato Takeuchi et al. · Cardiovascular Diabetology · 2018 · 122 citations · Full text

Medicine, Nutrition, Clinical Nutrition +15

Indirect measure of visceral adiposity ‘A Body Shape Index’ (ABSI) is associated with arterial stiffness in patients with type 2 diabetes

Ryotaro Bouchi, M Asakawa, Norihiko Ohara et al. · BMJ Open Diabetes Research & Care · 2016 · 121 citations · Full text

Medicine, Cardiology, Diabetology +14

Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial

Ryotaro Bouchi, Yujiro Nakano, Tatsuya Fukuda et al. · Endocrine Journal · 2016 · 110 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17